Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
Ahmedabad: Zydus Lifesciences has announced that the company has received the Establishment Investigation Report (EIR) report from the United States Food and Drug Administration (USFDA) for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park located at Changodar, Ahmedabad.
The inspection was held from 5th to 13th June, 2023.
The inspection was a cGMP Inspection and had ended with NIL observations.
Read also: Zydus Lifesciences incorporates wholly owned subsidiary company in Canada
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian Pharmaceutical company headquartered in Ahmedabad. The Company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. It is primarily engaged in the manufacture of generic drugs.
Read also: Zydus Lifesciences bags USFDA nod for antibacterial drug Erythromycin
